InflaRx Presentation:
Developing the First in Class Anti-C5a Antibody IFX-1: Lessons Learned from Clinical Trials
Presenter:
Prof. Niels Riedemann, CEO and Founder of InflaRx
Date:
Thursday, 14.11.2019
Time:
3:00 pm
Synopsis
More information...
<< back to list